Results 101 to 110 of about 7,838 (113)
Some of the next articles are maybe not open access.

Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models

Nature Reviews Drug Discovery, 2019
Richard J Weaver   +2 more
exaly  

The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative

International Journal of Molecular Sciences, 2016
Fernando Bessone   +2 more
exaly  

Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019

Frontiers in Pharmacology, 2019
Rolf Teschke
exaly  

Current limitations and future opportunities for prediction of DILI from in vitro

Archives of Toxicology, 2016
Adrian B Roth
exaly  

Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry

Clinical Gastroenterology and Hepatology, 2018
Inmaculada Medina-Caliz   +2 more
exaly  

Minimizing DILI risk in drug discovery — A screening tool for drug candidates

Toxicology in Vitro, 2015
Simone Schadt   +2 more
exaly  

Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993–Mid 2020: A Comprehensive Analysis

Medicines (Basel, Switzerland), 2020
Rolf Teschke, Gaby Danan
exaly  

Models of Drug Induced Liver Injury (DILI) – Current Issues and Future Perspectives

Current Drug Metabolism, 2018
Lucija Kuna   +2 more
exaly  

Recurrent Drug-Induced Liver Injury (DILI) with different drugs in the Spanish Registry: The dilemma of the relationship to autoimmune hepatitis

Journal of Hepatology, 2011
Mi Lucena, Marina Berenguer
exaly  

The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury

Expert Review of Gastroenterology and Hepatology, 2018
Shraddha Thakkar   +2 more
exaly  
mecmua
previous   9  10  11  12  

Home - About - Disclaimer - Privacy